KRMD Repro Med Systems

KORU Medical Systems Schedules Release of Second Quarter 2020 Financial Results and Conference Call

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the second quarter ended June 30, 2020 after the close of the financial markets on Tuesday, August 4, 2020. Management will host a conference call on Wednesday, August 5, 2020 at 9:00 am ET to discuss the results and business activities.

Interested parties may participate in the call by dialing:

  • (877) 407-9753 (Domestic) or
  • (201) 493-6739 (International)

Webcast registration:

Following the live call, a replay will be available for six months on the Company's website, under "Investor Relations."

About KORU Medical

KORU Medical manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information about the Company, please visit .

EN
27/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Repro Med Systems

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: January 30, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

KORU Medical Systems to Present at H.C. Wainwright BioConnect 2021 Con...

CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President and Chief Executive Officer, will provide a company overview at the H.C. Wainwright BioConnect 2021 Conference, held virtually from January 11-14, 2021. A copy of the presentation will be available on the “Investors” section of the Company’s website . About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality o...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch